RESUMEN
INTRODUCTION: Increased nuchal translucency is known to be associated with chromosomal and structural defects and genetic syndromes. Little is known about the overall long-term outcome of euploid children after increased nuchal translucency. The aims of this study were to assess the additional structural defects diagnosed after discharge from the delivery hospital and the long-term overall outcome of euploid children after increased nuchal translucency and normal second trimester anomaly scan. MATERIAL AND METHODS: All children from singleton euploid pregnancies during 2002-2007 with increased nuchal translucency in the first trimester screening, normal second trimester anomaly scan, and discharged as apparently healthy were included. Data on the structural defects and genetic disorders diagnosed until 2012 were retrieved from hospital databases and national registers. Previously published data of structural defects diagnosed after birth but before discharge and of severe neurodevelopmental impairment and genetic syndromes was added. RESULTS: The cohort included 733 children. During the follow-up time (mean 6.5 years), major structural defects were observed in 10 (1.4%), genetic disorders in two (0.3%), and minor defects in 23 (3.1%) children. In addition, there were 42 previously published major structural defects and major neurodevelopmental impairment or genetic disorders. Adding these results together, major health problems were detected in 54 (7%) euploid children with increased fetal nuchal translucency and normal findings in second trimester anomaly scan. CONCLUSION: Although only few additional major structural defects are diagnosed during the follow-up after increased fetal nuchal translucency, 7% of fetuses assumed to be healthy after second trimester anomaly scan have a major health impairment.
Asunto(s)
Anomalías Congénitas , Enfermedades Genéticas Congénitas , Medida de Translucencia Nucal , Adulto , Niño , Anomalías Congénitas/diagnóstico , Anomalías Congénitas/epidemiología , Femenino , Finlandia/epidemiología , Estudios de Seguimiento , Enfermedades Genéticas Congénitas/diagnóstico , Enfermedades Genéticas Congénitas/epidemiología , Humanos , Medida de Translucencia Nucal/métodos , Medida de Translucencia Nucal/estadística & datos numéricos , Valor Predictivo de las Pruebas , Embarazo , Primer Trimestre del Embarazo , Segundo Trimestre del Embarazo , PronósticoRESUMEN
OBJECTIVE: We aim to study the gender impact on the pregnancy outcome and on the long-term outcome of children after increased fetal nuchal translucency. METHOD: All singleton pregnancies with increased nuchal translucency (≥3 mm until 1 March 2004 and ≥95th percentile thereafter) referred to Helsinki University Hospital from 2002 to 2007 with known gender and normal sex chromosomes were included. The pregnancy outcome (miscarriage, termination of pregnancy, perinatal death or delivery of a healthy/unhealthy child) and the long-term outcome (structural defects or neurodevelopmental impairment) were recorded from hospital databases and national registers. RESULTS: Of the 1011 fetuses, 600 were male and 411 were female, male-to-female ratio being 1.46 : 1. This ratio decreased by increasing NT thickness, being 1 : 1 when the NT was ≥4.0 mm. The pregnancy outcome was better among male fetuses than among female fetuses (p = 0.049). There were more chromosomal abnormalities among the females than the males (p = 0.04). Among euploid fetuses, the pregnancy outcome and the long-term outcome were equal. CONCLUSION: After increased nuchal translucency, the pregnancy outcome of male fetuses was better due to the lower incidence of chromosomal abnormalities compared with female fetuses. Among euploid fetuses, the pregnancy outcome and the long-term outcome were equal.
Asunto(s)
Anomalías Congénitas/diagnóstico por imagen , Medida de Translucencia Nucal , Resultado del Embarazo , Niño , Preescolar , Trastornos de los Cromosomas/diagnóstico por imagen , Femenino , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Masculino , Embarazo , Factores SexualesRESUMEN
In persons afflicted with left or right atrial isomerism the intrathoracic and intra-abdominal organs are symmetrical. In left atrial isomerism the intrathoracic organs located on the right are similar to those on the left: lungs, for example, have two lobes and long bronchi. In right atrial isomerism there are three lobes of the lung and short bronchi also on the left side of the chest. Both malformation syndromes are associated with a complex structural anomaly of the heart. The prognosis continues to be poor. We describe an inherited gene defect found in five children in a Finnish family and causing right atrial isomerism.
Asunto(s)
Anomalías Múltiples/patología , Cardiopatías Congénitas/patología , Pulmón/anomalías , Anomalías Múltiples/genética , Finlandia , Predisposición Genética a la Enfermedad , Cardiopatías Congénitas/genética , Humanos , PronósticoAsunto(s)
Enfermedades Autoinmunes/genética , Bloqueo Cardíaco/congénito , Antígenos de Histocompatibilidad Clase II/genética , Antígenos de Histocompatibilidad Clase I/genética , Femenino , Predisposición Genética a la Enfermedad , Bloqueo Cardíaco/genética , Prueba de Histocompatibilidad , Humanos , Polimorfismo de Nucleótido SimpleRESUMEN
OBJECTIVES: The goals of this study are to assess pregnancy outcome with increased nuchal translucency (NT) and to determine the risk of adverse pregnancy outcome in relation to the degree of increased NT. METHODS: All singleton pregnancies with increased NT at the first screening ultrasound examination referred to the Department of Fetal Medicine at the Helsinki University Central Hospital during 2002 to 2007 were included. Pregnancy outcomes and short-term outcomes of the newborns were recorded and analyzed. RESULTS: Of the 1063 pregnancies, karyotype was normal in 834 (78%). The majority, 611 (73%), of euploid fetuses was in the lowest NT group (95th percentile--3.4 mm). Percentage of favorable outcome decreased from 92% in the lowest NT group (95th percentile--3.4 mm) to 18% in the highest NT group (≥6.5 mm). Structural defects or genetic disorders were observed in 74 (9%) of cases with normal karyotype, of which 43 (58%) resulted in live birth, 25 (34%) in termination of pregnancy, and 6 (8%) in miscarriage or perinatal death. CONCLUSIONS: Even minimal (95th percentile--3.4 mm) increase in NT thickness is associated with adverse pregnancy outcome also in euploid fetuses.
Asunto(s)
Medida de Translucencia Nucal , Resultado del Embarazo/epidemiología , Adolescente , Adulto , Largo Cráneo-Cadera , Reacciones Falso Positivas , Femenino , Enfermedades Fetales/diagnóstico por imagen , Enfermedades Fetales/epidemiología , Enfermedades Fetales/genética , Humanos , Recién Nacido , Cariotipificación , Persona de Mediana Edad , Medida de Translucencia Nucal/estadística & datos numéricos , Embarazo , Derivación y Consulta/estadística & datos numéricos , Estudios Retrospectivos , Adulto JovenRESUMEN
Right-atrial isomerism (RAI) is a heterotaxy syndrome with disturbances of left-right axis development resulting in complex heart malformations and anomalies of the thoracic and abdominal organs. To study the outcome of RAI, all data from patients diagnosed with this syndrome at Helsinki University Hospital between January 1976 and December of 2010 were reviewed. The outcomes were studied for 32 patients (38 % girls). The overall survival was 22 % at a median follow-up time of 13.8 years (range 0.1-33). Extracardiac malformations, mostly asplenic, occurred in 91 % of patients. Cardiac defects included dextrocardia in 44 % and common atrioventricular valve in 100 % of patients. Ventriculoarterial discordance or double-outlet ventricle was seen in 56 and 44 % of patients, respectively. Total anomalous pulmonary venous drainage occurred in 75 % and partially anomalous venous drainage in 13 % of patients. Pulmonary outflow-tract obstruction was identified in 91 % of patients. Cardiac arrhythmias were noted in nine patients (28 %), two of them with atrioventricular block. Cardiovascular surgery was performed in 71 % patients (N = 25), seven patients were inoperable. Biventricular repair was not possible in any of the patients. During long-term follow-up there was no significant difference between the patients with total, normal, or partially anomalous pulmonary venous drainage (P = 0.5). In conclusion, RAI is one of the most severe forms of congenital cardiac diseases. The prognosis remains poor despite modern surgical techniques. When RAI is identified during pregnancy, prenatal counseling, termination, or planning for prompt cardiac treatment after the birth is necessary.
Asunto(s)
Procedimientos Quirúrgicos Cardíacos/métodos , Predicción , Síndrome de Heterotaxia/epidemiología , Complicaciones Cardiovasculares del Embarazo , Adolescente , Adulto , Niño , Preescolar , Ecocardiografía , Femenino , Finlandia/epidemiología , Estudios de Seguimiento , Edad Gestacional , Síndrome de Heterotaxia/diagnóstico , Síndrome de Heterotaxia/cirugía , Humanos , Lactante , Recién Nacido , Masculino , Embarazo , Pronóstico , Estudios Retrospectivos , Factores de Riesgo , Ultrasonografía Prenatal , Adulto JovenRESUMEN
Right atrial isomerism (RAI) is a heterotaxy syndrome with disturbances in the left-right axis development, resulting in complex heart malformations and abnormal lateralization of other thoracic and abdominal organs. Although autosomal-recessive inheritance of heterotaxy syndrome is seen in multiple families, underlying gene defects have remained unknown. Here we identify the molecular genetic basis of a kindred with five siblings with RAI. Linkage analysis and positional candidate gene approach showed that the affected children were compound heterozygotes for truncating mutations in the growth/differentiation factor 1 (GDF1) gene. Individuals heterozygous for the mutations were clinically healthy. This finding, supported by the similar phenotype in Gdf1 knockout mouse, provides firm evidence that RAI can occur as a recessively inherited condition, with GDF1 as the culprit gene. The results will shed light on the biological basis of human laterality defects and facilitate molecular diagnosis of RAI.
Asunto(s)
Factor 1 de Diferenciación de Crecimiento/genética , Cardiopatías Congénitas/genética , Mutación , Secuencia de Aminoácidos , Secuencia de Bases , Preescolar , Análisis Mutacional de ADN , Femenino , Genes Recesivos , Factor 1 de Diferenciación de Crecimiento/fisiología , Atrios Cardíacos/anomalías , Cardiopatías Congénitas/diagnóstico , Humanos , Lactante , Recién Nacido , Masculino , Datos de Secuencia Molecular , Mutación/fisiología , Linaje , Embarazo , Situs Inversus/genéticaRESUMEN
Left atrial isomerism includes a complex spectrum of cardiac and extracardiac anomalies. The records of all patients with left isomerism born during the period of 1973-2010 and treated at the Children's Hospital, Helsinki were reviewed. The short- and long-term outcomes were studied. The review included 38 patients (50% females). The overall survival with left atrial isomerism was 63% during a median follow-up time of 16 years (range, 4-30 years). Extracardiac anomalies were noted in 14 (37%) of 38 cases. Cardiac defects included dextrocardia in 26%, partially or totally anomalous pulmonary venous return in 29%, common atrium in 50%, atrioventriculoseptal defect in 73%, single ventricle in 40%, ventriculoseptal defect without atrioventricular defect in 11%, transposition in 21%, double outlet of the right ventricle in 26%, pulmonary stenosis or atresia in 61%, and left ventricular outflow obstruction in 24% of the cases. Cardiac arrhythmias were presented in 71% and pacemaker treatment in 29% of the cases. Of the 38 patients, 33 had cardiac surgery. Simple palliative methods were used in 11 cases, single-ventricle palliation in 12 cases, and operation with a biventricular track in 10 cases. In the groups that had surgery, 3 of 11 patients, 3 of 12 patients, and 3 of 10 patients died, respectively. In this review, 14 deaths occurred, associated with extracardiac anomalies in five cases and with cardiac arrhythmia in four cases. Five postoperative deaths occurred. At this writing, all three patients who had heart transplantation are alive. Complicated heart defects associated with severe arrhythmias and extracardiac anomalies contribute to a high mortality rate with left isomerism. Cardiac transplantation was considered a good option for selected patients.
Asunto(s)
Procedimientos Quirúrgicos Cardíacos/métodos , Atrios Cardíacos/anomalías , Síndrome de Heterotaxia/cirugía , Niño , Preescolar , Femenino , Finlandia/epidemiología , Estudios de Seguimiento , Atrios Cardíacos/cirugía , Síndrome de Heterotaxia/diagnóstico , Síndrome de Heterotaxia/mortalidad , Humanos , Lactante , Recién Nacido , Masculino , Cuidados Paliativos/métodos , Pronóstico , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia/tendencias , Factores de TiempoRESUMEN
Pulmonary atresia with intact ventricular septum (PA+IVS) is a rare congenital cardiac malformation which is associated with ventriculocoronary arterial communications from the right ventricle. We present a case of PA+IVS with a bilateral atresia of the coronary ostia, and thus, a completely right ventricular-dependent coronary circulation followed up by fetal echocardiography. Eventually the infant died of myocardial infarction at 2 days of age.
Asunto(s)
Anomalías de los Vasos Coronarios/diagnóstico por imagen , Tabiques Cardíacos/diagnóstico por imagen , Atresia Pulmonar/diagnóstico por imagen , Ultrasonografía Prenatal , Adulto , Biopsia , Angiografía Coronaria , Anomalías de los Vasos Coronarios/patología , Resultado Fatal , Femenino , Humanos , Recién Nacido , Masculino , Infarto del Miocardio/diagnóstico , EmbarazoRESUMEN
OBJECTIVE: The objectives of this follow-up study of 292 fetuses with various cardiac arrhythmias were to estimate the incidence of structural heart defects and fetal compromise, to investigate the effects of antiarrhythmic medication, and to evaluate perinatal mortality and morbidity and long-term outcome. METHODS: The arrhythmias were classified into atrial extrasystoles (n = 200), atrial tachycardias (n = 35), atrioventricular block (n = 36), sinus bradycardia (n = 14), and ventricular extrasystoles (n = 7), and outcome of the infants was analyzed. RESULTS: The incidence of cardiac anomalies was 12% in the study population. In utero cardiac failure was noted in 11%. Among fetuses with atrial extrasystoles, 1% developed supraventricular tachycardia after birth. During antiarrhythmic therapy, sinus rhythm was achieved in 92% of nonhydropic and in 63% of hydropic fetuses. The latter had higher mortality and risk for neurologic morbidity than did nonhydropic fetuses; 38% versus 3.7% and 40% versus 12%, respectively. Among fetuses with atrioventricular block only, the survival rate was 82%, with a heart defect, prognosis was poor: 50% survived. Sinus bradycardia and ventricular extrasystoles were associated with survival rates of 75% and 67%. In the follow-up of the whole study population lasting a median 5 years, 93% are alive and 3% have a neurologic disorder. CONCLUSION: All fetal arrhythmias except atrial extrasystoles were associated with a moderately high risk for fetal distress. In cases of compromise, fetal and neonatal prognosis was poor and was an indication for perinatal medication. After the newborn period, the prognosis has been good. However, the risk for neurologic morbidity must be taken into consideration.
Asunto(s)
Arritmias Cardíacas/complicaciones , Enfermedades Fetales , Arritmias Cardíacas/tratamiento farmacológico , Arritmias Cardíacas/epidemiología , Protocolos Clínicos , Femenino , Enfermedades Fetales/tratamiento farmacológico , Estudios de Seguimiento , Cardiopatías Congénitas/epidemiología , Cardiopatías Congénitas/etiología , Humanos , Incidencia , Recién Nacido , Masculino , Estudios Retrospectivos , Factores de Tiempo , Resultado del TratamientoAsunto(s)
Cardiopatías Congénitas/diagnóstico , Cardiopatías Congénitas/terapia , Ultrasonografía Prenatal , Femenino , Edad Gestacional , Cardiopatías Congénitas/fisiopatología , Humanos , Recién Nacido , Embarazo , Resultado del Embarazo , Pronóstico , Índice de Severidad de la Enfermedad , Factores de TiempoRESUMEN
OBJECTIVES: Despite recent advances in the treatment of children with univentricular heart, their neurodevelopmental outcome remains a major concern. METHODS: This prospective follow-up study evaluated the neurodevelopmental outcome of 23 patients with hypoplastic left heart syndrome, 14 with other forms of univentricular heart, and 46 healthy control subjects at a median age of 12.2 months. The Griffiths Developmental Scale and Alberta Infant Motor Scale served for developmental evaluation. RESULTS: The mean Griffiths developmental quotient of children with hypoplastic left heart syndrome was significantly less (91.6) than that of control children (106.8, P < .001). Patients with univentricular heart scored significantly lower than control subjects only in the gross motor domain (P = .001) but not in overall development (100.6). Alberta Infant Motor Scale scores were significantly lower in children with hypoplastic left heart syndrome (37.5, P < .001) and univentricular heart (43.5, P = .011) than in control subjects (53.3). In linear regression a diagnosis of hypoplastic left heart syndrome (P = .016), a clinical history of seizure (P = .002), and the highest plasma lactate level after the bidirectional Glenn operation (P = .045) were significantly associated with the developmental quotient. CONCLUSIONS: At age 1 year, the level of development of children with univentricular heart was significantly lower than for control subjects only in motor skills, whereas children with hypoplastic left heart syndrome had a more widespread developmental delay. The diagnosis, a clinical seizure history, and increased plasma lactate levels after the bidirectional Glenn operation emerged as risk factors.
Asunto(s)
Desarrollo Infantil , Síndrome del Corazón Izquierdo Hipoplásico/fisiopatología , Síndrome del Corazón Izquierdo Hipoplásico/cirugía , Femenino , Estudios de Seguimiento , Humanos , Lactante , Masculino , Pruebas Neuropsicológicas , Estudios ProspectivosRESUMEN
OBJECTIVE: Despite improved survival and neurodevelopmental outcome, children with hypoplastic left heart syndrome and other forms of univentricular heart remain at increased risk for cognitive, motor, and other neurologic deficits. METHODS: We examined 27 children with hypoplastic left heart syndrome or other forms of univentricular heart at a median age of 5.70 years (range 4.99-7.51 years) and performed brain computed tomography or magnetic resonance imaging on 20. Possible risk factors were correlated with outcome. RESULTS: Mean full-scale IQ among patients with hypoplastic left heart syndrome was 86.7; that among patients with other forms of univentricular heart was 89.1, with both differing significantly from the expected population mean (P = .015 and P = .029, respectively). Cerebral palsy was diagnosed in 1 of 7 patients with hypoplastic left heart syndrome and 2 of 20 with other forms of univentricular heart. Brain computed tomography or magnetic resonance imaging revealed ischemic changes and infarcts or atrophy in 5 of 8 patients who had undergone the Norwood procedure and in 2 of 12 of those who had not (P = .062). Abnormal computed tomographic findings correlated significantly with lower full-scale IQ (P = .045) and verbal IQ (P = .02). In the multiple linear regression model, diuresis the third day after the primary operation and cardiopulmonary bypass time in the bidirectional Glenn operation correlated significantly with the primary outcome of full-scale IQ. CONCLUSION: In children with univentricular heart, intellectual and neurologic deficits are common. Perioperative and postoperative risk factors related to the primary phase and bidirectional Glenn operation contribute to these deficits.
Asunto(s)
Discapacidades del Desarrollo/etiología , Síndrome del Corazón Izquierdo Hipoplásico/cirugía , Pruebas Neuropsicológicas , Desempeño Psicomotor/fisiología , Niño , Preescolar , Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/etiología , Discapacidades del Desarrollo/diagnóstico , Femenino , Humanos , Pruebas de Inteligencia , Modelos Lineales , Imagen por Resonancia Magnética , Masculino , Examen Neurológico , Factores de Riesgo , Estadísticas no Paramétricas , Tomografía Computarizada por Rayos XRESUMEN
BACKGROUND: The aim of this study was to assess the etiology and outcome of fetuses with functional heart disease as detected by echocardiography. METHODS: In total, 51 fetuses (median gestation age of 28.6 weeks) were included. The inclusion criteria were hydrops (n = 14), pericardial effusion (PE; n = 9), tricuspid valve regurgitation (TR; n = 8), hypertrophic cardiomyopathy (HCM; n = 7) and dilated cardiomyopathy (DCM; n = 7). Antenatal management was performed for 17 of 51 fetuses (33%): two abortions, nine digoxin administrations, three thoracocenteses, one pericardial puncture, one blood transfusion and one ascites centesis. RESULTS: The etiology of functional heart disease was twin pregnancy in 18, fetal lung lesions in five, maternal diabetes in five, fetal anemia in four, extracardiac or chromosomal abnormalities in three, infection in three, teratoma or arteriovenous malformation in four, indomethacin administration in two, endocardial fibroelastosis in two, maternal anaphylaxia in one, idiopathic arterial calcification of infancy (IACI) in one, pregnancy-induced hypertension (PIH) in one, and unknown in two fetuses. There was no significant difference between fetuses with and without treatment (53% vs. 79%; p = 0.06). There were two stillbirths and 12 postnatal deaths (29%). Among 35 surviving infants, 85% were free of symptoms in the follow-up (mean 3.9 years). CONCLUSIONS: These findings indicate that a functional heart disease in utero is associated with very varying etiology and high mortality. Improved understanding of the hemodynamic findings may lead to treatment that is more successful.
Asunto(s)
Cardiopatías Congénitas/diagnóstico por imagen , Cardiopatías Congénitas/epidemiología , Ultrasonografía Prenatal , Adulto , Ecocardiografía , Femenino , Finlandia/epidemiología , Edad Gestacional , Cardiopatías Congénitas/embriología , Cardiopatías Congénitas/etiología , Humanos , Embarazo , Resultado del Embarazo , Embarazo MúltipleRESUMEN
OBJECTIVE: The aim of the study was to review the outcome of fetuses with structural heart disease detected by echocardiography. METHODS: A total of 99 fetuses with different types of cardiac defects, diagnosed at a median gestational age of 28.4 weeks (range 16-41 weeks), were included. The inclusion criteria were a structural heart defect confirmed postnatally or at post-mortem examination, and a complete, long-term follow-up in utero and after birth in the Hospital for Children and Adolescents, Helsinki, Finland from 1983 to 1999. RESULTS: Of 99 fetuses with in utero diagnosed cardiac anomalies, 6 (6%) showed normal cardiac status postnatally. Thirty-five percent of fetuses (n = 10) with heart disease diagnosed before 24 weeks of gestation were terminated. Of 83 fetuses, 7 (8%) with a heart defect died in utero at a median gestational age of 33 weeks. Chromosomal abnormality was found in 28% of cases. Fetuses with normal chromosomes had extracardiac anomalies in 40% of cases. Mortality due to chromosomal abnormality was 73% and from extracardiac anomaly 48%. Intrauterine heart failure was detected in 27% of fetuses and was frequently associated with univentricular heart (UVH) and intracardiac tumors, in 36 and 67%, respectively; 12 fetuses (13%) were found to have associated arrhythmia; 4 of these died. Of 76 live births (median gestational age 38 weeks, birth weight 2878 g), a total of 37 (49%) neonates died. Twenty-four neonates (32%) underwent cardiac surgery or invasive procedure; six infants (25%) died after the procedure. Neonatal mortality was highest in fetuses with hypoplastic left heart syndrome (HLHS), ventricular septal defect (VSD), and UVH (87, 64, and 50%, respectively). In long-term follow-up (median 3.8 years), 34 children of 76 live births (45%) were alive, 59% of them were without symptoms. CONCLUSION: Our data indicate that despite elective, planned delivery the prognosis for fetuses with in utero diagnosed heart defect was poor. The outcome was largely attributable to associated extracardiac malformations and chromosomal abnormalities.
Asunto(s)
Enfermedades Fetales/diagnóstico por imagen , Cardiopatías Congénitas/diagnóstico por imagen , Ultrasonografía Prenatal , Adolescente , Adulto , Aberraciones Cromosómicas/embriología , Femenino , Enfermedades Fetales/genética , Enfermedades Fetales/mortalidad , Estudios de Seguimiento , Edad Gestacional , Cardiopatías Congénitas/genética , Cardiopatías Congénitas/mortalidad , Humanos , Recién Nacido , Persona de Mediana Edad , Embarazo , Pronóstico , Estudios RetrospectivosRESUMEN
OBJECTIVE: To study the autoimmune response in mothers of children with isolated congenital heart block (CHB) and heart block (HB) diagnosed postnatally. METHODS: We reviewed the Finnish hospital registries for patients born between 1950 and 2000 and diagnosed with isolated HB before the age of 16 years. Clinical data and sera for the determination of autoantibodies were available from 67 mothers of children with CHB and from 37 mothers of children with postnatally diagnosed HB 9.9 years and 22.6 years (mean) after the index delivery, respectively. Maternal antibodies to 52 kDa and 60 kDa SSA and 48 kDa SSB were determined by time-resolved fluoroimmunoassay (TR-FIA) and by immunoblotting. Other marker antibodies for connective tissue diseases (CTD) were determined by immunoblot and/or by immunofluorescence. The control group comprised 136 mothers with primary Sjögren's syndrome (SS), systemic lupus erythematosus (SLE), or other CTD with healthy children. RESULTS: Sixty of our 67 mothers (90%) of children with CHB had antibodies to SSA or SSB by the methods initially used in this study. When retests and tests performed previously were taken into account, only 3 (4%) of the 67 mothers did not have any autoantibodies. Two (3%) of the 67 mothers had antibodies to dsDNA and one (1%) each to Jo-1/HRS, RNP-70 kDa, and histone proteins. Of 37 mothers of children with postnatally diagnosed HB, only 3 (8%) had any autoantibodies. Increased risk of having a child with CHB was indicated by maternal primary SS and high levels of anti-SSA and anti-SSB by all assays, whereas low risk was indicated by maternal SLE or other CTD and undetectable or low levels of the antibodies. No single anti-SSA or anti-SSB test was clearly superior to others, but in general, immunoblots were more specific than TR-FIA. CONCLUSION: Maternal autoimmune disorder is almost always associated with CHB but only rarely with postnatally diagnosed HB. Anti-SSA and anti-SSB are marker antibodies for mothers of children with CHB, and an increased risk of having an affected child is indicated by maternal primary SS and high titer antibodies to SSA and SSB.